查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405757

藥物研發發現資訊學市場規模、佔有率、趨勢分析報告：按工作流程、服務、區域、細分市場預測，2023-2030

Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Workflow (Discovery Informatics, Biocontent Management), By Services (Sequence Analysis Platform), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

藥物研發發現資訊學市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球藥物研發發現資訊學市場規模預計將達到68.6億美元，2023年至2030年複合年成長率為11.2%。

近年來，由於快速藥物設計和合成、有效追蹤疾病進展以及資料完整性管理等多種優勢，使用藥物研發軟體獲取市場資訊已受到研究人員的歡迎，其數量顯著增加，並正在推動藥物發現的成長。行業。

對新型分子不斷成長的需求正在推動資訊學解決方案的採用，這些解決方案旨在透過目標大分子相互作用來識別合理的藥物分子，從而加速整個藥物研發過程。在該市場營運的公司正在獲得財務支持，以擴大其藥物研發平台，進一步補充市場成長。例如，2020年9月，Aldigen與國家研發中心簽署協議，獲得開發新技術的經費。

該技術旨在徹底改變基於 T 細胞受體的免疫腫瘤治療方法的開發。 Ardigen 先前開發了新抗原預測平台ArdImmune Vax，這是一種即用型人工智慧(AI) 和生物資訊解決方案，用於識別最佳新抗原作為過繼性細胞療法和癌症疫苗的標靶。我們正在擴展。此外，化學資訊學解決方案在過去一年中獲得了巨大的關注，特別是在滿足與最近的 COVID-19 大流行相關的需求方面。

例如，在2021年1月進行的一項研究中，為了加速尋找SARS-CoV-2 Mpro抑制劑，對SARS-CoV主要蛋白酶（Mpro）抑制劑歷史活性資料進行了化學數字資料，並介紹了該解決方案的應用。此外，QSAR 模型對於快速藥物研發的分子資料探勘很有用。因此，加速 COVID-19 藥物開發的需求預計將推動未來幾年的產業擴張。

藥物研發發現資訊學市場報告亮點

  • 由於臨床階段中的候選藥物數量不斷增加，預計從 2022 年到 2030 年，藥物開發工作流程領域的年複合成長率(CAGR)。
  • 到 2022 年，藥物研發發現資訊學領域將佔最大收益佔有率，約 60%，主要關注精準醫療的開發。精準醫學的核心是提供根據個人遺傳和分子特徵量身定做的個人化醫療。
  • 由於主要市場參與者的存在以及成熟的研發基礎設施，以美國主導在 2022 年引領全球市場。
  • 主要市場參與企業都將重點放在策略性收購上，以維持市場競爭。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章藥物研發發現資訊學市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 藥物研發資訊學市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章藥物研發發現資訊學：工作流程估計與趨勢分析

  • 藥物研發發現資訊學市場：重點
  • 藥物研發發現資訊學市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 發現資訊學
  • 生物含量管理

第5章藥物研發發現資訊學：服務估計與趨勢分析

  • 藥物研發發現資訊學市場：重點
  • 藥物研發發現資訊學市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 序列分析平台
  • 分子建模
  • 對接
  • 臨床試驗資料管理
  • 其他

第6章藥物研發資訊市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的藥物研發資訊市場：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • Certara
    • Boehringer Ingelheim International GmbH
    • Infosys Ltd.
    • Charles River Laboratories
    • Collaborative Drug Discovery, Inc.
    • Eurofins DiscoverX Products
    • Jubilant Biosys
    • Selvita
    • Novo Informatics Pvt. Ltd.
    • ChemAxon Ltd.
    • Albany Molecular Research Inc.
    • Oracle
    • Accenture
    • Agilent Technologies, Inc.
    • Illumina, Inc.
Product Code: 978-1-68038-749-0

Drug Discovery Informatics Market Growth & Trends:

The global drug discovery informatics market size is expected to reach USD 6.86 billion by 2030, registering a CAGR of 11.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. Use of drug discovery software for gaining market intelligence owing to several advantages, such as rapid drug design & synthesis, efficient tracking of disease evolution, and data integrity management, has increased significantly among the researchers in the recent years, driving the industry growth.

The growing demand for novel molecules is driving the adoption of informatics solutions targeted towards speeding up the entire drug discovery process by identifying rational drug molecules via the target macromolecule interaction. Companies operating in the market are receiving funding for expanding their drug discovery platforms, further supplementing the market growth. For instance, in September 2020, Ardigen signed an agreement with the National Centre for Research and Development to access its funding for developing novel technology.

This technology was aimed at revolutionizing the development of T-cell receptors-based therapies for immuno-oncology. Ardigen has previously developed a neoantigen prediction platform namely, ArdImmune Vax, which deploys ready-to-use Artificial Intelligence (AI) and bioinformatics solutions for the identification of optimal sets of neoantigens as targets for adoptive cell therapies and cancer vaccines. In addition, chemical informatics solutions have gained considerable traction in the past year, particularly in addressing the needs associated with the recent COVID-19 pandemic.

For instance, a research study performed in January 2021 showcased the application of chemical digital solutions in accelerating the search of SARS-CoV-2 Mpro inhibitors by data analysis of previous activity data of SARS-CoV main protease (Mpro) inhibitors. In addition, the QSAR models helped in the data mining of molecules for rapid COVID-19 drug discovery. Hence, the need to facilitate drug development for COVID-19 is expected to propel the industry expansion over the coming years.

Drug Discovery Informatics Market Report Highlights:

  • The drug development workflow segment is projected to exhibit the highest compound annual growth rate (CAGR) of 10.9% from 2022 to 2030 owing to a rise in the number of drug candidates in the clinical development phase
  • The discovery informatics segment accounted for the largest revenue share of around 60% in 2022, with a major focus on developing precision medicines. Precision medicine revolves around providing personalized medical care tailored to an individual's genetic and molecular profile.
  • Led by the U.S., North America led the global market in 2022 due to the presence of key market players and established R&D infrastructure in the country
  • Key industry participants focus on strategic acquisitions to sustain the market competition

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Workflow
    • 1.1.2. Services
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Workflow outlook
    • 2.2.2. Services outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Discovery Informatics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Drug Discovery Informatics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Drug Discovery Informatics: Workflow Estimates & Trend Analysis

  • 4.1. Drug Discovery Informatics Market: Key Takeaways
  • 4.2. Drug Discovery Informatics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Discovery Informatics
    • 4.3.1. Discovery Informatics market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Biocontent Management
    • 4.4.1. Biocontent Management market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Drug Discovery Informatics: Services Estimates & Trend Analysis

  • 5.1. Drug Discovery Informatics Market: Key Takeaways
  • 5.2. Drug Discovery Informatics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Sequence Analysis Platform
    • 5.3.1. Sequence analysis platform market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.4. Molecular Modelling
    • 5.4.1. Molecular Modelling market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.5. Docking
    • 5.5.1. Docking market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.6. Clinical Trial Data Management
    • 5.6.1. Clinical Trial Data Management market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Drug Discovery Informatics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Drug Discovery Informatics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Certara
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Boehringer Ingelheim International GmbH
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Infosys Ltd.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Charles River Laboratories
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Collaborative Drug Discovery, Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Eurofins DiscoverX Products
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Jubilant Biosys
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Selvita
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Novo Informatics Pvt. Ltd.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. ChemAxon Ltd.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Albany Molecular Research Inc.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Oracle
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Accenture
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Agilent Technologies, Inc.
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. Illumina, Inc.
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 3 North America drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 4 North America drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 U.S. drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 7 U.S. drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 8 Canada drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 9 Canada drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 10 Canada drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 11 Europe drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 12 Europe drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 13 Europe drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 14 Germany drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 15 Germany drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 16 Germany drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 17 UK drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 UK drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 19 UK drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 20 France drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 21 France drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 22 France drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 23 Italy drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 24 Italy drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 25 Italy drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 26 Spain drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Spain drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 28 Spain drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 29 Sweden drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 30 Sweden drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 31 Sweden drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 32 Norway drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 33 Norway drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 34 Norway drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 35 Denmark drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 36 Denmark drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 37 Denmark drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 41 China drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 42 China drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 43 China drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 45 Japan drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 46 Japan drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 47 India drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 48 India drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 49 India drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 50 Thailand drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 51 Thailand drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 52 Thailand drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 53 South Korea drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 54 South Korea drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 55 South Korea drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 56 Latin America drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 57 Latin America drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 58 Latin America drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 59 Brazil drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 60 Brazil drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 61 Brazil drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 62 Mexico drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 63 Mexico drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 64 Mexico drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 65 Argentina drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 66 Argentina drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 67 Argentina drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 68 Middle East and Africa drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 69 Middle East and Africa drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 70 Middle East and Africa drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 71 South Africa drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 72 South Africa drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 73 South Africa drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 74 Saudi Arabia drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 75 Saudi Arabia drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 76 Saudi Arabia drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 77 UAE drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 78 UAE drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 79 UAE drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 80 Kuwait drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 81 Kuwait drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 82 Kuwait drug discovery informatics market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig.1 Market research process
  • Fig.2 Data triangulation techniques
  • Fig.3 Primary research pattern
  • Fig.4 Market research approaches
  • Fig.5 Value-chain-based sizing & forecasting
  • Fig.6 QFD modeling for market share assessment
  • Fig.7 Market formulation & validation
  • Fig.8 Drug Discovery Informatics s: market outlook
  • Fig.9 Drug Discovery Informatics s competitive insights
  • Fig.10 Parent market outlook
  • Fig.11 Related/ancillary market outlook
  • Fig.12 Penetration and growth prospect mapping
  • Fig.13 Industry value chain analysis
  • Fig.14 Drug Discovery Informatics market driver impact
  • Fig.15 Drug Discovery Informatics market restraint impact
  • Fig.16 Drug Discovery Informatics market strategic initiatives analysis
  • Fig.17 Drug Discovery Informatics market: Workflow movement analysis
  • Fig.18 Drug Discovery Informatics market: Workflow outlook and key takeaways
  • Fig.19 Discovery informatics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.20 Biocontent management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.22 Drug Discovery Informatics market: Services movement analysis
  • Fig.23 Drug Discovery Informatics market: Services outlook and key takeaways
  • Fig.24 Sequence analysis platforms market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.25 Molecular modelling market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.26 Docking market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.27 Clinical trial data management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.29 Global Drug Discovery Informatics market: regional movement analysis
  • Fig.30 Global Drug Discovery Informatics market: regional outlook and key takeaways
  • Fig.31 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.32 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.34 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.35 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.37 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.38 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.39 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.40 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.41 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.44 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.45 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.46 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.48 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.49 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.50 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.51 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.52 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.53 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.54 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.56 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.57 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.58 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)